Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoid
- PMID: 32179081
- DOI: 10.1016/j.jaad.2020.03.017
Interleukin 4 and interleukin 13 inhibition: A promising therapeutic approach in bullous pemphigoid
Keywords: antibody; bullous pemphigoid; dupilumab.
Comment on
-
Dupilumab as a novel therapy for bullous pemphigoid: A multicenter case series.J Am Acad Dermatol. 2020 Jul;83(1):46-52. doi: 10.1016/j.jaad.2020.01.089. Epub 2020 Mar 13. J Am Acad Dermatol. 2020. PMID: 32179082
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
